Dykstra: Take Aim Again on Amgen

Bottom line, Amgen has a boatload of new drugs in the pipeline, and this stock is way oversold -- and with the stock so cheap, value investors will start moving in and scooping up shares. So let's take advantage of it.

It was hammered after the first time I bought it, and it continued to get beat up to the point I know many of you were wondering, why keep buying? Answer: The cream always rises to the top. It's not a matter of if, it's a matter of when.

We are going to buy 10 deep-in-the-money (DITM) calls, going all the way until January 2008, where we will use the 45 strike (WAMAI) with a $12.50 limit order. It is important to be patient on an order like this. The January 45 traded $12.50 on Friday; I will let it come in. Remember, you are in the driver's seat, you are in control; don't let anything, or anybody, get in the way of your decision. It's very simple: The man with the gold makes the rules.

Game of Life

As we enter mid-May, the weather is warming, and so are the bats in baseball. (It is no secret that hitters prefer the warmer weather.) Four of the six divisional races in baseball are highly competitive, while the NL Central and the AL East are threatening to become runaways, owing to the marvelous play of the Milwaukee Brewers and the Boston Red Sox, respectively.